{"title":"The Lost Leading the Lost: A Surrogacy Conundrum","authors":"Jenay Powell MD","doi":"10.1016/j.jpainsymman.2025.02.061","DOIUrl":null,"url":null,"abstract":"<div><h3>Outcomes</h3><div>1. Participants will develop a framework for thinking critically about and analyzing their experiences with evaluating capacity at the end of life.</div><div>2. Participants will think critically about evaluating the appropriateness of surrogate decision-makers at the end of life and how this might be incorporated into their practice.</div></div><div><h3>Key Message</h3><div>This presentation takes a case-based approach to crucial issues at the intersection of ethics and palliative care. It is a close dissection of how we think about capacity, surrogate decision-making, and what it means to act in the best interest of the patient.</div></div><div><h3>Abstract</h3><div>(The Case) Gertie is a 93-year-old with advanced dementia admitted with a UTI to a community hospital. She is essentially nonverbal, says one to two words in your 30-minute inpatient intake visit. She is accompanied by her lifelong friend, Dale. He has lived with her for more than 20 years and they have no other family. You and your team meet with Dale, in his 80s, at the bedside. They have never talked about what she would have at end-of-life. While Dale acknowledges that they need more help than he can provide at home, he is unsure of what his next decision should be. Information about hospice is provided. Two days later, you meet with Dale as planned. It becomes clear that he does not recall your last conversation. How do we decide what happens to Gertie?</div></div><div><h3>Results / Resolution</h3><div>In this case, an informal conversation was had with some of the Ethics consultants at an affiliated institution who provided additional clarity. Because Gertie was not safe to be discharged home, and there was no additional treatment to offer, the threshold for competency was fairly low, because there was no safe alternative. The decision was made to have her discharge to a nursing home facility with hospice overlay.</div></div><div><h3>Conclusion</h3><div>So often we ask patients to designate surrogate decisionmakers in the event they are incapacitated, but we may fail or be unable to verify the appropriateness or capacity of the surrogates themselves until we are already in a dire situation. In cases where surrogate decisionmakers are of advanced age, it might be reasonable to ask patients to nominate multiple surrogates who they feel might be able to call on to act in their best interests.</div></div><div><h3>References</h3><div>Appelbaum PS. Clinical practice. Assessment of patients' competence to consent to treatment. N Engl J Med. 2007 Nov 1;357(18):1834-40. doi: 10.1056/NEJMcp074045. PMID: 17978292.</div></div>","PeriodicalId":16634,"journal":{"name":"Journal of pain and symptom management","volume":"69 5","pages":"Pages e447-e448"},"PeriodicalIF":3.2000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pain and symptom management","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0885392425001216","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Outcomes
1. Participants will develop a framework for thinking critically about and analyzing their experiences with evaluating capacity at the end of life.
2. Participants will think critically about evaluating the appropriateness of surrogate decision-makers at the end of life and how this might be incorporated into their practice.
Key Message
This presentation takes a case-based approach to crucial issues at the intersection of ethics and palliative care. It is a close dissection of how we think about capacity, surrogate decision-making, and what it means to act in the best interest of the patient.
Abstract
(The Case) Gertie is a 93-year-old with advanced dementia admitted with a UTI to a community hospital. She is essentially nonverbal, says one to two words in your 30-minute inpatient intake visit. She is accompanied by her lifelong friend, Dale. He has lived with her for more than 20 years and they have no other family. You and your team meet with Dale, in his 80s, at the bedside. They have never talked about what she would have at end-of-life. While Dale acknowledges that they need more help than he can provide at home, he is unsure of what his next decision should be. Information about hospice is provided. Two days later, you meet with Dale as planned. It becomes clear that he does not recall your last conversation. How do we decide what happens to Gertie?
Results / Resolution
In this case, an informal conversation was had with some of the Ethics consultants at an affiliated institution who provided additional clarity. Because Gertie was not safe to be discharged home, and there was no additional treatment to offer, the threshold for competency was fairly low, because there was no safe alternative. The decision was made to have her discharge to a nursing home facility with hospice overlay.
Conclusion
So often we ask patients to designate surrogate decisionmakers in the event they are incapacitated, but we may fail or be unable to verify the appropriateness or capacity of the surrogates themselves until we are already in a dire situation. In cases where surrogate decisionmakers are of advanced age, it might be reasonable to ask patients to nominate multiple surrogates who they feel might be able to call on to act in their best interests.
References
Appelbaum PS. Clinical practice. Assessment of patients' competence to consent to treatment. N Engl J Med. 2007 Nov 1;357(18):1834-40. doi: 10.1056/NEJMcp074045. PMID: 17978292.
期刊介绍:
The Journal of Pain and Symptom Management is an internationally respected, peer-reviewed journal and serves an interdisciplinary audience of professionals by providing a forum for the publication of the latest clinical research and best practices related to the relief of illness burden among patients afflicted with serious or life-threatening illness.